We have formed a board of advisers made up of experienced clinical practitioners and experts in the field to help us get this work done. Currently this board consists of David Cavan, MD, FRCP; Mark Cucuzzella MD, FAAFP; Robert Cywes, MD, PhD; Georgia Ede, MD; Gary Fettke, MB, BS, FRACS, FAOrthA; Brian Lenzkes, MD; Timothy D. Noakes, MD, DSc; Bret Scher, MD; Franziska Spritzler, RD, CDE; David Unwin, FRCGP; Eric C. Westman, MD, MHS; and William S. Yancy, Jr., MD, MSH.
Work is now underway to generate condition-specific addenda for these Clinical Guidelines. It is clear that for certain chronic diseases the general intervention is not always enough. Nuances and caveats often exist that can make the intervention more successful.
This Clinical Guidelines document will be updated from time to time as the science evolves. If you download or print this document out it is imperative that you return to this page from time to time to ensure that you have the latest version. Onn the right are links to the pdf versions and the various language translations.
Patient safety and support is of the highest importance. For practitioners who do not have prescribing/de-prescribing privileges, this means ensuring that all patients using therapeutic carbohydrate restriction are assisted in adjusting medications as needed by a professional trained in this process.
Read the Statement of Support, then please complete the form if you would like to have your name listed on there as well.
Available Translations
Become a part of our community dedicated to advancing metabolic health. Sign up today to gain access to specialized content, connect with fellow practitioners, and contribute to the future of metabolic health. Your journey starts here!
Log in to access your profile and membership content